Mustang Bio Inc.

MBIO | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.55

+$0.01 (+1.91%)

At close: Sep 21, 2026, 4:00 PM ET

$0.55

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.91%

(1D)

Rating

Updated: Sep 19, 2026

21.2

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $4.17M

1D Range

0.53 0.56

52W Range

0.47 1.85

Valuation (TTM)

PE -1.22

PB 0.55

EV/EBITDA 3.62

Valuation (NTM)

Forward PE N/A

Forward PEG 0.03

Price Target N/A

Cash Flow

FCF Yield -133.5%

SBC Adj. FCF Yield -135.6%

SBC Impact -1.6%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 88.0% | 58.0%

FCF 3Y | 5Y 82.4% | 52.2%

Returns

ROA -19.4%

ROE -34.2%

ROIC -45.8%

Financial Health

Net Cash

$15.15M

Current Ratio 1.97

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company...

Sector Healthcare

Industry Biotechnology

Employees 4

IPO Date Aug 21, 2017

Website www.mustangbio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.